|
CDS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.24790178190892E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79400050370759E-10 |
| Normal-vs-Stage2 |
5.423400E-04 |
| Normal-vs-Stage3 |
2.60940002938526E-09 |
| Normal-vs-Stage4 |
1.77479997365282E-09 |
| Stage1-vs-Stage2 |
1.768620E-01 |
| Stage1-vs-Stage3 |
4.456600E-01 |
| Stage1-vs-Stage4 |
6.105800E-02 |
| Stage2-vs-Stage3 |
9.270300E-02 |
| Stage2-vs-Stage4 |
1.453710E-02 |
| Stage3-vs-Stage4 |
2.440000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.8219874194142E-12 |
| Normal-vs-AfricanAmerican |
3.680100E-03 |
| Normal-vs-Asian |
8.22580000003903E-07 |
| Caucasian-vs-AfricanAmerican |
2.251000E-01 |
| Caucasian-vs-Asian |
7.249600E-01 |
| AfricanAmerican-vs-Asian |
3.867400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.24990001576708E-09 |
| Normal-vs-Female |
5.52069945314315E-10 |
| Male-vs-Female |
3.064600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.75279951348296E-10 |
| Normal-vs-Age(41-60Yrs) |
7.64259999730399E-09 |
| Normal-vs-Age(61-80Yrs) |
9.07919994741491E-09 |
| Normal-vs-Age(81-100Yrs) |
1.390030E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.887400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.537600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.426600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.979200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.549200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.952800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.264000E-03 |
| Classical-VS-Follicular |
7.271600E-01 |
| Classical-VS-Other |
2.991200E-01 |
| Classical-VS-Normal |
8.55939985555665E-10 |
| Tall-VS-Follicular |
3.715700E-02 |
| Tall-VS-Other |
8.484600E-01 |
| Tall-VS-Normal |
1.2380000358192E-09 |
| Follicular-VS-Other |
4.505200E-01 |
| Follicular-VS-Normal |
1.40630000000641E-06 |
| Other-VS-Normal |
3.140700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.553699474106E-10 |
| Normal-vs-N1 |
1.45680001395476E-09 |
| N0-vs-N1 |
1.011150E-01 |
|
|
